PINX:IMMY Insider Activity 3 Filing - 2/15/2012

Effective Date 2/15/2012

PINX:IMMY (): Fair Value Estimate
Premium
PINX:IMMY (): Consider Buying
Premium
PINX:IMMY (): Consider Selling
Premium
PINX:IMMY (): Fair Value Uncertainty
Premium
PINX:IMMY (): Economic Moat
Premium
PINX:IMMY (): Stewardship
Premium
 
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Finnegan Paul
2. Date of Event Requiring Statement (Month/Day/Year)
02/15/2012
3. Issuer Name and Ticker or Trading Symbol
Imprimis Pharmaceuticals, Inc. [IMMY]
(Last)
(First)
(Middle)
IMPRIMIS PHARMACEUTICALS, INC., 437 S HWY 101, STE 209
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)

SOLANA BEACH, CA 92075
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option (Right to Buy) 02/28/2012(1) 01/22/2017 Common Stock 625,000 $0.64 D  
Option (Right to Buy) 04/01/2012(2) 03/31/2017 Common Stock 125,000 $0.9 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Finnegan Paul
IMPRIMIS PHARMACEUTICALS, INC.
437 S HWY 101, STE 209
SOLANA BEACH, CA 92075
  X      

Signatures

Paul Finnegan 04/27/2012
** Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The stock options, granted on January 23, 2012 and effective as of February 28, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Mr. Finnegan's options vest over a 3 year period at a strike price of $0.64, with the initial 250,000 options vesting on January 6, 2013, the next 250,000 options vesting on January 6, 2014, and the final 125,000 options vesting on January 6, 2015.
(2) The stock options, granted on April 1, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Mr. Finnegan's options maintain a strike price of $0.90, and vest quarterly over a one year term with the initial 31,250 options vesting on June 30, 2012, the next 31,250 options vesting on September 30, 2012, the next 31,250 options vesting on December 31, 2012 and the final 31,250 options vesting on March 31, 2013.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

PINX:IMMY Insider Activity 3 Filling

PINX:IMMY Stock - Get Insider Activity SEC Filing of PINX:IMMY stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

PINX:IMMY Insider Activity 3 Filing - 2/15/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: PINX:IMMY Insider Activity 3 Filing - 2/15/2012  |  Next: PINX:IMMY Insider Activity 3 Filing - 2/28/2012